FTC/FDA Cease and Desist Letters to Companies Touting Diabetes Cures: Is the FTC Testing the Limits of Its Civil Penalty Authority?

September 13, 2021

FDA Rejects CBD New Dietary Ingredient Notifications: Four Practical Takeaways

August 13, 2021

Dietary Supplement and Personal Care Products Regulatory and Litigation Highlights – May and June 2021

July 16, 2021

Food Industry Regulatory and Litigation Highlights – June 2021

July 16, 2021

Food Industry Regulatory and Litigation Highlights – April and May 2021

June 4, 2021

Dietary Supplement and Personal Care Products Regulatory and Litigation Highlights – April 2021

May 9, 2021

FTC Files First Case Seeking Civil Penalties For Allegedly Deceptive COVID-19 Advertising

April 19, 2021

Food Industry Regulatory and Litigation Highlights – March 2021

April 18, 2021

Dietary Supplement and Personal Care Product Regulatory and Litigation Highlights – March 2021

April 16, 2021

FDA Enforcement: There’s Nothing Inactive About CBD and “FDA Registered” Is Misleading

March 26, 2021